Cardiol Therapeutics Inc. (TSX:CRDL)
Canada
· Delayed Price · Currency is CAD 1.430
+0.100 (7.52%)
At close: Dec 5, 2025
Cardiol Therapeutics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
141.36M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.78B |
| dentalcorp Holdings | 1.66B |
| Green Thumb Industries | 1.61B |
| Sienna Senior Living | 967.05M |
| Extendicare | 1.59B |
| Trulieve Cannabis | 1.66B |
| Cronos Group | 184.36M |
| WELL Health Technologies | 1.25B |
Cardiol Therapeutics News
- 3 days ago - Cardiol Therapeutics Inc To Present Phase II ARCHER Results Transcript - GuruFocus
- 4 days ago - Cardiol Therapeutics (CRDL): HC Wainwright & Co. Reiterates Buy Rating | CRDL Stock News - GuruFocus
- 5 days ago - New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions - Newsfile Corp
- 23 days ago - Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040 - Newsfile Corp
- 4 weeks ago - Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases - Newsfile Corp
- 6 weeks ago - Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027 - Newsfile Corp
- 7 weeks ago - Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027 - Newsfile Corp
- 4 months ago - Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 45th Annual Growth Conference - Newsfile Corp